Protein Expression Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 2.88 Billion |
| Market Size (2029) | USD 4.29 Billion |
| CAGR (2024 - 2029) | 8.23 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players.webp "Global Protein Expression Market Major Players")
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Protein Expression Market Analysis
The Global Protein Expression Market size is estimated at USD 2.88 billion in 2024, and is expected to reach USD 4.29 billion by 2029, growing at a CAGR of 8.23% during the forecast period (2024-2029).
The market has a slightly positive impact due to the pandemic. The development of therapeutic and preventive strategies requires an accurate understanding of the role that proteins play in the SARS-CoV-2 infection process and progression of COVID-19. The vast field of proteomics is well equipped with the technologies needed to help in facing this challenge. In an article published in October 2020 in the Journal of Proteins and Proteomics, researchers have highlighted that the developments in proteome technologies will not only accelerate progress in addressing the coronavirus pandemics but could also prove invaluable in tackling the current COVID-19 crisis.
The propelling factors for the growth of the protein expression market include the rise in the R&D activity in the pharmaceutical sector, opportunities in the field of proteomics, and advancements in the biologics market set to boost the market growth and the increasing incidences of chronic diseases. As per the World Health Organization, the major chronic diseases such as cardiovascular diseases (CVD), cancer, chronic obstructive pulmonary disease, and Type 2 diabetes are estimated to account for 73% of all deaths and 60% of the global burden of diseases in 2020.
Biologics have played a crucial role in the treatment process of many health issues. The success of Humira, a drug for the treatment of rheumatoid arthritis, has been an encouraging factor for many drug makers to continue working in the pathway of biologics. The growing demand for biologicals increases the prospects of its manufacturing using the protein expression systems, thus, boosting the market growth.
In addition, biotechnology-based organizations have also created a big opportunity for the protein expression market growth by developing novel therapeutics with minimal side effects. The increasing research intensity in the pharmaceutical sector is adding up to the opportunities for growth by technological advancement and product launch. For instance, in October 2020, Merck launched the Virus Express Lentiviral Production Platform, which can reduce process development time by approximately 40%.
Therefore, at present, the protein expression market is a highly attractive and profitable market due to the increasing adoption of biotechnology as well as genetic engineering in the pharmaceutical industry and medical science. However, the high cost of protein expression systems and lack of effective systems for post-translational modifications are expected to restrain the market growth over the forecast period.
Protein Expression Market Trends
This section covers the major market trends shaping the Protein Expression Market according to our research experts:
Cell-free Expression is Expected to Hold a Major Market Share in the Protein Expression Market
The cell-free protein expression is well-established in the market, due to its acceptance, and this protein expression is performed without the use of living cells. This technique has many advantages over other protein expression techniques and because of its advantages, it is widely used. Due to the advantages of cell-free protein techniques, such as increased speed, ability to express toxic proteins, ease of amino acid type selective labeling, among others, these are making the cell expression market grow.
Furthermore, the growing launches of cell-free systems boost the usage of the kits and reagents. For instance, in 2019, Arbor Biosciences announced the launch of myTXTLTM bulk offerings of cell-free expression systems. These new offerings align with the growing demand for larger volume requirements by organizations utilizing high-throughput screening in protein and enzyme engineering. These cell-free expression systems are currently available from Arbor Biosciences as a Sigma 70 or a linear DNA expression master mix.
Moreover, the growing research and studies on cell-free systems, especially due to COVID is further boosting the growth of the segment. In the article 'Combating COVID-19 with Cell-Free Expression' published in October 2020, synthetic biologists pivoted the cell-free expression technology that they were using for other diseases to develop new diagnostics, materials, and treatments specifically for COVID-19.
Therefore, the unique technology may increase the growth of the cell-free expression market, which in turn, is expected to boost the protein expression market.
North America is the Largest Growing Market and is Expected to Continue the Same Trend Over the Forecast Period
North America is the largest market for protein expression and is expected to dominate the overall protein expression market due to factors like the presence of well-established healthcare infrastructure in these regions combined with the intense R&D activities carried out. The US protein expression market is driven by factors, such as an increase in the usage of protein technologies, the rapid evolution of the pharmaceutical industry in the region, and the presence of several companies in the region itself.
As per the January 2021 report of the American Cancer Society, there will be an estimated 1,898,160 new cases of cancer, and 608,570 people will die from it. The increasing demand and acceptance of gene and monoclonal antibody-based therapies in the treatment of diseases such as cancer, rare diseases, and other disorders are also driving the growth of the protein expression market in the region.
According to the Statistics Canada May 2021 report titled 'The Canadian Research and Development Pharmaceutical Sector,' in 2018, the pharmaceutical sector added almost USD 15 billion in value-added to the Canadian economy and spent about USD 1.5 billion to USD 2 billion on research and development during the same period of time.
The growing patient population and growing research and development funding in the region is boosting the market growth.
Protein Expression Industry Overview
The protein expression market is fragmented. The companies present have a broad product portfolio with comprehensive features and have a strong geographical presence. Furthermore, these leaders cater to the requirements of major end users, such as research laboratories and pharmaceutical and biotechnology companies. Some of the companies which are currently dominating the market are Agilent Technologies Inc., Bio-Rad Technologies, Thermo Fisher Scientific Inc., Merck KGA, Takara Bio Inc., New England Biolabs Inc., Oxford Expression Technologies Ltd, Promega Corporation, Qiagen NV, and Sigma-Aldrich Corporation.
Protein Expression Market Leaders
-
Agilent Technologies Inc
-
Thermo Fisher Scientific Inc
-
Merck KGaA
-
Takara Bio Inc
-
New England Biolabs Inc
*Disclaimer: Major Players sorted in no particular order
Protein Expression Market News
- In September 2021, Aviva Systems Biology, one of the market leaders in antibodies, immunoassay kits, and recombinant proteins for life science research, launched its new Protein on Demand, a semi-custom recombinant protein portfolio for life scientists conducting basic research and preclinical studies.
- In June 2021, Qiagen launched CRISPR products for the analysis of edited genetic material with high speed and efficiency. The products were QIAprep& CRISPR Kit and CRISPR Q-Primer Solution.
Protein Expression Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising R&D Activity in the Pharmaceutical Sector
- 4.2.2 Escalation in the Biologics Market
- 4.2.3 Government Support for Proteomics and Genomics Research
-
4.3 Market Restraints
- 4.3.1 High Cost of Protein Expression Systems
- 4.3.2 Lack of Effective Systems for Post-translational Modifications
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Reagents and Kits
- 5.1.1.1 Cell-free Expression
- 5.1.1.2 Bacterial Expression
- 5.1.1.3 Yeast Expression
- 5.1.1.4 Algal Expression
- 5.1.1.5 Insect Expression
- 5.1.1.6 Mammalian Expression
- 5.1.1.7 Other Expression Systems
- 5.1.2 Service
- 5.1.3 Other Products
-
5.2 By Application
- 5.2.1 Therapeutic
- 5.2.2 Industrial
- 5.2.3 Research
-
5.3 By End User
- 5.3.1 Academia
- 5.3.2 Biotechnology and Pharmaceuticals Companies
- 5.3.3 Contract Research Organizations (CROs)
-
5.4 By Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle-East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle-East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Agilent Technologies Inc.
- 6.1.2 Bio-Rad Laboratories Inc.
- 6.1.3 Merck KGaA
- 6.1.4 New England Biolabs Inc.
- 6.1.5 Oxford Expression
- 6.1.6 Promega Corporation
- 6.1.7 Qiagen NV
- 6.1.8 Takara Bio Inc.
- 6.1.9 Thermo Fisher Scientific Inc.
- 6.1.10 Lonza Bioscience
- 6.1.11 Synthetic Genomics Inc.
- 6.1.12 Sino Biological Inc.
- 6.1.13 Bioneer Corporation
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityProtein Expression Industry Segmentation
As per the scope of the report, protein expression is the way in which proteins are modified, synthesized, and regulated in living organisms. The term is applicable to either the object of study or the laboratory techniques required to manufacture proteins. Proteins are regulated and synthesized depending upon the functional need in the host cell. The translation, transcription, and post-translational modifications are the three processes involved in protein expression. The protein expression market is segmented by product (reagent and kits, service, and other products), application (therapeutic, industrial, and research), end user (academia, biotechnology and pharmaceuticals companies, and contract research organizations (CROs)), and geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.
| By Product | Reagents and Kits | Cell-free Expression |
| Bacterial Expression | ||
| Yeast Expression | ||
| Algal Expression | ||
| Insect Expression | ||
| Mammalian Expression | ||
| Other Expression Systems | ||
| By Product | Service | |
| Other Products | ||
| By Application | Therapeutic | |
| Industrial | ||
| Research | ||
| By End User | Academia | |
| Biotechnology and Pharmaceuticals Companies | ||
| Contract Research Organizations (CROs) | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle-East and Africa | GCC |
| South Africa | ||
| Rest of Middle-East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Protein Expression Market Research FAQs
How big is the Global Protein Expression Market?
The Global Protein Expression Market size is expected to reach USD 2.88 billion in 2024 and grow at a CAGR of 8.23% to reach USD 4.29 billion by 2029.
What is the current Global Protein Expression Market size?
In 2024, the Global Protein Expression Market size is expected to reach USD 2.88 billion.
Who are the key players in Global Protein Expression Market?
Agilent Technologies Inc, Thermo Fisher Scientific Inc, Merck KGaA, Takara Bio Inc and New England Biolabs Inc are the major companies operating in the Global Protein Expression Market.
Which is the fastest growing region in Global Protein Expression Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Protein Expression Market?
In 2024, the North America accounts for the largest market share in Global Protein Expression Market.
What years does this Global Protein Expression Market cover, and what was the market size in 2023?
In 2023, the Global Protein Expression Market size was estimated at USD 2.66 billion. The report covers the Global Protein Expression Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Protein Expression Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Protein Expression Industry Report
Statistics for the 2024 Protein Expression market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Protein Expression analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
